177Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer

Thorsten Derlin; Liam Widjaja; Rudolf A. Werner; Frank M. Bengel

doi:10.2967/jnumed.122.264293

Research ArticleBRIEF COMMUNICATION

¹⁷⁷Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer

Thorsten Derlin, Liam Widjaja, Rudolf A. Werner and Frank M. Bengel

Journal of Nuclear Medicine January 2023, 64 (1) 54-58; DOI: https://doi.org/10.2967/jnumed.122.264293

Thorsten Derlin

Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Liam Widjaja

Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rudolf A. Werner

Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Frank M. Bengel

Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Article Information

vol. 64 no. 1 54-58

DOI

https://doi.org/10.2967/jnumed.122.264293

PubMed

35853739

Published By

Society of Nuclear Medicine

Print ISSN

0161-5505

Online ISSN

2159-662X

History

Received for publication April 14, 2022
Revision received July 12, 2022
Published online January 4, 2023.

Article Versions

previous version (July 19, 2022 - 12:00).
You are viewing the most recent version of this article.

Author Information

Thorsten Derlin,
Liam Widjaja,
Rudolf A. Werner and
Frank M. Bengel

Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany

For correspondence or reprints, contact Thorsten Derlin (derlin.thorsten{at}mh-hannover.de).

View Full Text

Statistics from Altmetric.com

Cited By...

9 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer

Nicolai Mader, Christina Nguyen Ngoc, Bilge Kirkgöze, Justus Baumgarten, Daniel Groener, Konrad Klimek, Christian Happel, Nikolaos Tselis, Felix K. H. Chun, Frank Grünwald, Amir Sabet

European Journal of Nuclear Medicine and Molecular Imaging 2023 50 6
How Can Radiopharmaceutical Therapies Reach Their Full Potential? Improving Dose Reporting and Phase I Clinical Trial Design

Ana P. Kiess, Joseph O'Donoghue, Carlos Uribe, Lisa Bodei, Robert F. Hobbs, Jacob Hesterman, Adam L. Kesner, George Sgouros, Tom Bäck, Manuel Bardies, Alessandro Bartolini, Sören Bentzen, Peter Bernhardt, Ingrid Bloise, Lisa Bodei, Wesley Bolch, Patrik Brodin, Julia Brosch-Lenz, Jacek Capala, Carlo Chiesa, Patricia E. Cole, Marta Cremonesi, Emmanuel Deshayes, Yuni Dewaraja, Roberto Formento-Cavaier, Gerhard Glatting, Harwig Hennekes, Jacob Hesterman, Rob Hobbs, Vicki Jardine, Jessica Jensen, Adam Kesner, Ana P. Kiess, Mark W. Konijnenberg, Clemens Kratochwil, Phillip H. Kuo, Roberto Maass-Moreno, Michael Morris, Quyen Nguyen, Joseph O'Donoghue, Stig Palm, Neeta Pandit-Taskar, Laurens Raes, Hendrik Rathke, Babak Saboury, Nicola Salem, Lore Santoro, Oliver Sartor, Mike Sathekge, George Sgouros, Eileen Sneeden, Lidia Strigari, Scott Tagawa, Carlos Uribe, Amanda Walker, Wolfgang Weber, Fred Wilson, Tahir Yusufaly, Sabine Zitzmann-Kolbe

Journal of Clinical Oncology 2024 42 15
Prostate-Specific Membrane Antigen: Gateway to Management of Advanced Prostate Cancer

Lena M. Unterrainer, Jeremie Calais, Neil H. Bander

Annual Review of Medicine 2024 75 1
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer

Hong Song, Maria Isabel Leonio, Valentina Ferri, Heying Duan, Carina Mari Aparici, Guido Davidzon, Benjamin L. Franc, Farshad Moradi, Jagruti Shah, Colin P. Bergstrom, Alice C. Fan, Sumit Shah, Ali Raza Khaki, Sandy Srinivas, Andrei Iagaru

European Journal of Nuclear Medicine and Molecular Imaging 2024 51 9
Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics

Ayman Abouzayed, Panagiotis Kanellopoulos, Alisa Gorislav, Vladimir Tolmachev, Theodosia Maina, Berthold A. Nock, Anna Orlova

Biomolecules 2023 13 7
Cancer therapy–related salivary dysfunction

Cristina Paz, Annemarie Glassey, Abigail Frick, Sarah Sattar, Nicholas G. Zaorsky, Grace C. Blitzer, Randall J. Kimple

Journal of Clinical Investigation 2024 134 17
Comparative Analysis of Morphological and Functional Effects of 225Ac- and 177Lu-PSMA Radioligand Therapies (RLTs) on Salivary Glands

Benedikt Feuerecker, Andrei Gafita, Thomas Langbein, Robert Tauber, Christof Seidl, Frank Bruchertseifer, Jürgen E. Gschwendt, Wolfgang A. Weber, Calogero D’Alessandria, Alfred Morgenstern, Matthias Eiber

International Journal of Molecular Sciences 2023 24 23
RECIP 1.0 + PSA for response assessment in mCRPC patients treated with 225Ac / 177Lu PSMA combination therapy

Gabriel T. Sheikh, Astrid Delker, Mathias J. Zacherl, Adrien Holzgreve, Sarah L. Takayama Fouladgar, Marcus Unterrainer, Johannes Rübenthaler, Jozefina Casuscelli, Andrei Gafita, Lena M. Unterrainer

EJNMMI Research 2025 15 1
Radiation-Therapy Related Salivary Dysfunction

Grace C. Blitzer, Cristina Paz, Sara S. McCoy, Randall J. Kimple

Seminars in Radiation Oncology 2025 35 2

Article usage

Article usage: July 2022 to February 2025

	Abstract	Full	Pdf
Jul 2022	1649	0	90
Aug 2022	910	0	40
Sep 2022	493	0	32
Oct 2022	346	0	12
Nov 2022	322	0	15
Dec 2022	135	0	7
Jan 2023	1240	47	60
Feb 2023	648	24	24
Mar 2023	585	11	31
Apr 2023	387	15	15
May 2023	315	12	14
Jun 2023	309	9	8
Jul 2023	59	231	18
Aug 2023	48	346	30
Sep 2023	43	276	25
Oct 2023	36	147	30
Nov 2023	43	170	26
Dec 2023	27	83	21
Jan 2024	42	251	29
Feb 2024	21	248	27
Mar 2024	14	177	25
Apr 2024	40	88	27
May 2024	19	55	20
Jun 2024	38	111	24
Jul 2024	100	149	42
Aug 2024	85	129	41
Sep 2024	15	65	33
Oct 2024	20	65	26
Nov 2024	16	79	34
Dec 2024	20	70	21
Jan 2025	31	63	19
Feb 2025	12	125	26

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 64, Issue 1

January 1, 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following 177Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

¹⁷⁷Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer

Thorsten Derlin, Liam Widjaja, Rudolf A. Werner, Frank M. Bengel

Journal of Nuclear Medicine Jan 2023, 64 (1) 54-58; DOI: 10.2967/jnumed.122.264293

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

¹⁷⁷Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer

Thorsten Derlin, Liam Widjaja, Rudolf A. Werner, Frank M. Bengel

Journal of Nuclear Medicine Jan 2023, 64 (1) 54-58; DOI: 10.2967/jnumed.122.264293

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

prostate-specific membrane antigen
PSMA
177Lu-PSMA
duration
treatment extension
therapy

Main menu

User menu

Search

¹⁷⁷Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer

Article Information

Article Versions

Author Information

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: July 2022 to February 2025

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords